Climate Action 100+: Is the $68tr investor group failing to drive 'meaningful progress' from top emitters?

Michael Holder
clock • 5 min read
Credit: iStock
Image:

Credit: iStock

ShareAction warns world’s largest climate investor group is at risk of greenwashing - but Climate Action 100+ insists it is pushing climate issues into the corporate mainstream

Climate Action 100+, the world's largest green activist investor group, has been accused of failing to deliver any meaningful progress in pushing the biggest global emitters to slash their emissions over...

To continue reading this article...

Join BusinessGreen

In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:

  • Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
  • Receive important and breaking news stories via our daily news alert
  • Our weekly newsletter with the best of the week’s green business news and analysis

Join now

 

Already a BusinessGreen member?

Login

More on Investment

National Wealth Fund provides £300m loan guarantee to Haweswater Aqueduct Resilience Programme

National Wealth Fund provides £300m loan guarantee to Haweswater Aqueduct Resilience Programme

Rachel Reeves hails deal as evidence of how new government-backed fund is catalysing investment and enhancing climate resilience

James Murray
clock 22 August 2025 • 2 min read
Survey: Younger people leading drive towards greener pensions

Survey: Younger people leading drive towards greener pensions

OVO-commissioned study reveals under 35s are nearly three times more likely than those over 65 to know exactly where their pension is invested

BusinessGreen staff
clock 21 August 2025 • 2 min read
Meatable acquires Uncommon's cultivated meat platform

Meatable acquires Uncommon's cultivated meat platform

Lab grown meat pioneer pledges to progress and scale up Uncommon Bio's alternative protein innovation, after Cambridge-based firm shifts focus to therapeutic products

Stuart Stone
clock 21 August 2025 • 4 min read